Improving medication management for elderly surgical patients
Implementation and Impact of Multidisciplinary Medication Review in Surgery Departments on Medication Management of Elderly Patients
This study tests whether having a pharmacist and a doctor work together can help older surgical patients manage their medications more safely and effectively.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 297 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de Nīmes Academic / other |
| Locations | 4 sites (Grenoble and 3 other locations) |
| Trial ID | NCT03827031 on ClinicalTrials.gov |
What this trial studies
This study evaluates the impact of having a clinical pharmacist and a general practitioner work together in surgery departments to enhance medication management for elderly patients. The approach involves conducting multidisciplinary medication reviews and providing follow-up support from community pharmacists. The goal is to ensure safer and more effective medication use among patients aged 65 and older who are on multiple medications. By focusing on this vulnerable population, the study aims to address the complexities of medication management in a surgical context.
Who should consider this trial
Good fit: Ideal candidates are elderly patients aged 65 and older who are hospitalized in surgery departments and are taking at least five medications.
Not a fit: Patients receiving palliative care or those participating in other interventional studies may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved medication safety and health outcomes for elderly patients undergoing surgery.
How similar studies have performed: Previous studies have shown that multidisciplinary approaches to medication management can improve patient outcomes, suggesting potential success for this study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The patient (or their representative) has given his consent and signed the consent form. * The patient is affiliated to a health insurance programme. * The patient is at least 65 years old (≥) treated by at least (≥) five medications for at least (≥) 6 months * The patient is available for a follow-up of 3 months. * The patient is hospitalized in the surgery department. * Patient with a Trivalle score greater than or equal to 2 (≥). * Patient living in a nursing home or going back home after hospitalization. Exclusion Criteria: * The subject is participating in another category I interventional study. * The subject is in an exclusion period determined by another study. * The subject is under safeguard of justice. * It is not possible to give the patient (or his/her trusted-person) informed information. * Palliative care
Where this trial is running
Grenoble and 3 other locations
- Chu de Grenoble — Grenoble, France (Not_yet_recruiting)
- CHU de Montpellier — Montpellier, France (Recruiting)
- Nimes University Hospital — Nîmes, France (Recruiting)
- CHU de Toulouse — Toulouse, France (Recruiting)
Study contacts
- Principal investigator: Jean-Marie Kinowski — Nîmes University Hospital
- Study coordinator: Jean-Marie Kinowski
- Email: jean.marie.kinowski@chu-nimes.fr
- Phone: +33(0)4.66.68.31.04
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.